The COVID-19 and TB syndemic: the way forward
The COVID-19 and TB syndemic: the way forward
dc.contributor.author | Trajman, A. | |
dc.contributor.author | Felker, I. | |
dc.contributor.author | Alves, L. C. | |
dc.contributor.author | Coutinho, I. | |
dc.contributor.author | Osman, M. | |
dc.contributor.author | Meehan, S-A. | |
dc.contributor.author | Singh, U. B. | |
dc.contributor.author | Schwartz, Y. | |
dc.date.accessioned | 2025-01-24T17:21:35Z | |
dc.date.available | 2025-01-24T17:21:35Z | |
dc.date.issued | 2022 | |
dc.description.abstract | Together, SARS-CoV-2 and M. tuberculosis have killed approximately 5.7 million people worldwide over the past 2 years. The COVID-19 pandemic, and the non- pharmaceutical interventions to mitigate COVID-19 transmission (including social distancing regulations, partial lockdowns and quarantines), have disrupted healthcare services and led to a reallocation of resources to COVID-19 care. There has also been a tragic loss of healthcare workers who succumbed to the disease. This has had consequences for TB services, and the fear of contracting COVID-19 may also have contributed to reduced access to TB services. Altogether, this is projected to have resulted in a 5-year setback in terms of mortality from TB and a 9-year setback in terms of TB detection. In addition, past and present TB disease has been reported to increase both COVID-19 fatality and incidence. Similarly, COVID-19 may adversely affect TB outcomes. From a more positive perspective, the pandemic has also created opportunities to improve TB care. In this review, we highlight similarities and differences between these two infectious diseases, describe gaps in our knowledge and discuss solutions and priorities for future research. | |
dc.identifier.citation | Trajman A, Felker I, Alves LC, Coutinho I, Osman M, Meehan SA, Singh UB, Schwartz Y. The COVID-19 and TB syndemic: the way forward. Int J Tuberc Lung Dis. 2022 Aug 1;26(8):710-719. doi: 10.5588/ijtld.22.0006. | |
dc.identifier.other | DOI: 10.5588/ijtld.22.0006 | |
dc.identifier.uri | https://dspace.inc.saude.gov.br/handle/123456789/743 | |
dc.language.iso | en | |
dc.publisher | The International Journal of Juberculosis and Lung Disease | |
dc.subject | SARS-CoV-2 | en |
dc.subject | coronavirus | en |
dc.subject | pandemic | en |
dc.subject | mortality. | en |
dc.title | The COVID-19 and TB syndemic: the way forward | |
dc.type | Article |
Arquivos
Original bundle
1 - 1 de 1
- Nome:
- Trajman A et al_INT J TUBERC LUNG DIS.pdf
- Tamanho:
- 84.64 KB
- Formato:
- Adobe Portable Document Format
- Descrição:
License bundle
1 - 1 de 1
thumbnail.default.placeholder
- Nome:
- license.txt
- Tamanho:
- 1.71 KB
- Formato:
- Item-specific license agreed to upon submission
- Descrição: